Summary: Insulin-like growth factors (IGFs) are evolutionarily conserved peptides that are essential for normal animal growth and development. Recent studies utilizing cell cultures suggest that the bioactivity of IGFs could be modulated by several high-affinity IGF-binding proteins (IGFBPs). The in vivo roles of these IGFBPs, however, are poorly defined. Research in this area has relied heavily on rodent models, and attempts have been hampered by the inaccessibility of the mammalian fetus which is enclosed in the uterus. We have been using a model teleost fish, the zebrafish, to investigate the role of IGFBPs in specifying the IGF actions in vivo. To date, cDNAs encoding several IGFBPs have been cloned and characterized from zebrafish, and their spatial and temporal expression profiles mapped. The results indicated that the structure and expression patterns of these molecules are highly conserved in fish. In cultured zebrafish cells, both IGFBP-1 and -2 act as inhibitors of IGF actions. To determine how IGFBP functions in vivo, IGFBP-2 was targeted expressed in the zebrafish embryos. Using these transgenic fish, the actions of IGFBP-2 in specifying IGF actions were investigated, and the results indicated that IGFBP-2 can inhibit fish growth in a ligand dependent manner.
INTRODUCTION
The size of an animal or organ is affectedprimarily by the number and size of its cells. While cell number depends on both cell proliferation and cell death, cell sizes are the result of cell growth and differentiation. Growth (increase in size) is therefore affected by the proliferative events out balancing cell death, with additional contributions by cell hypertrophy and deposition of extracellular materials. This process begins early in embryogenesis and lasts until a steady state is reached in postnatal stage. One of the most challenging questions facing the field of regulatory biology is to understand what are the developmental signals that control the body or organ size. Current views hold that growth is brought about by the operation of intracellular signaling pathways controlled by a network of growth factors and hormones. Most research on the developmental role of IGFBPs has relied on rodent models, and attempts to elucidate the molecular and cellular basis of IGFBP actions have been difficult due to the inaccessibility of the mammalian fetus enclosed in the uterus and the redundancy of multiple IGFBPs. Unlike mammalian embryos which live within the uterus and are dependent on maternal contributions through the placenta, fish embryos and larva grow freely in water. Hence, the accessibility and rapid development of teleost fish, make them well-suited for investigating the mechanisms by which IGFs, IGF IR, and IGFBPs act to regulate cell proliferation, differentiation, and apoptosis in early life stages. The transparency of zebrafish embryos provide an additional, immense advantage to their use in developmental studies and makes zebrafish a particularly suitable model system for investigating the mechanisms of IGF actions during early development.
In the past decade, there has been a rapid accumulation of knowledge of IGF biology in teleost fish. The structures of IGF-I and IGF-II have been determined in a large number of teleost species. Full length and partial sequences of IGF-IR have been reported for several fish, and major intracellular signaling pathways of IGF actions in fish elucidated. In addition, the full-length structure of several fish IGFBPs has been determined, and their proteins produced and characterized. Since information concerning the fish IGFs and IGF-IRs has been the topics of several speakers in this symposium and has been recently reviewed (3-6), I confine myself to the latest publications related to the fish IGFBPs in this paper. Special attention will be given to IGFBP-2 because it is not only the first fish IGFBP cloned but also the only fish IGFBP studied functionally. were obtained when 12 I-IGF-II was used as radioligand (Fig. 113) . Therefore, the cDNA cloned from zebrafish encodes a functional IGFBP that binds to IGF-I and IGF-II with high affinity and specificity. The spatial and temporal expression pattern implicates IGFBP-2 in growth regulation in fish. We next sought to determine the effect of IGFBP-2 in modulating IGF actions using cultured zebrafish cells (ZF-4 cells). The mitotic cells were identified by immunostaining of 5 bromo-2-deoxyuridine (BrdU) incorporated in the nuclei of dividing cells. As shown in Fig. 3 , exposure of confluent ZF-4 cells to IGF-I (100 ng/ml) resulted in a 7-fold increase in the number of proliferative cells. When added to the cultures at concentrations up to 5%, conditioned media (CMs) prepared from either wild-type Fig. 3 or mock-transfected cells did not cause any notable change in basal DNA synthesis levels. Addition of the cell media containing zebrafish IGFBP-2 resulted in a moderate, but statistically insignificant, decrease. When coincubated with IGF-I, the zebrafish IGFBP-2 containing cell media inhibited IGF-I-stimulated DNA synthesis in zebrafish cells in a concentration-dependent manner. At the concentration of 1%, it completely abolished the IGF-I effect (Fig. 3) . Wild-type and mock-transfected cell media had no such inhibitory effects. Similar results were also obtained by thymidine incorporation assay. These data indicated that IGFBP-2 inhibits IGF-I-induced cell proliferation in vitro.
To directly test the importance of IGFBP-2 in zebrafish embryos in vivo, we took a genetic approach to over express IGFBP-2 in zebrafish. When IGFBP-2 is overexposed globally in zebrafish using an expression construct driven by the CMV promoter, the transgenic embryos had a significantly higher rate of mortality compared to the vector-injected or non-injected control groups. The surviving IGFBP-2 transgenic embryos are growth retarded and had abnormal morphology (Fig.  4d ). This effect is specific, because the IGFBP-2 caused growth retardation and abnormal morphology can be "rescued" by co -expression of IGF-I (Fig . 4e) . These studies indicate that IGFBP-2 can inhibit growth of developing zebrafish embryos by binding to endogenous IGFs and preventing them from binding to the IGF receptors. For a full understanding of the physiological function of IGFBP-2 in vivo, a targeted gene ablation approach is needed. The developmental regulation mechanisms that govern the spatial and temporal expression of the IGFBP-2 gene have not been studied. Furthermore, the structure, expression, and function of other IGFBPs are almost entirely undefined in fish. Thus, more research activity using the zebrafish and other fish are needed to further our understanding of the role of the IGF signaling system in regulating growth and development. An better understanding of the underlying mechanisms governing growth and development of fish will undoubtedly contribute to the basic physiology of vertebrates in general as well as the aquaculture industry.
